Author, date and country | Patient group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
---|---|---|---|---|---|
Kumar N.L. et al 2016 USA | Review paper of 9 selected papers which included 3 RCTs, 1 prospective cohort trial and 5 retrospective cohort trials | Review article | Mortality | Only 1 out of the 9 studies showed statistically significant difference between early (< 13h) and standard (<24h) for high risk NVUGIB | Not a systematic review. Studies included differed significantly in their design Different definition of “early” |
Rebleeding | Of the 5 studies, none reported any statistically significant difference | ||||
Surgery | Only 1 out of the 8 studies reported statistically significant difference | ||||
Length of stay | 4 out of 8 studies reported statistically significant difference, predominantly in those where early is defined as within 24 hours | ||||
Chen et al 2012 Taiwan | 101 patients with active oesophageal variceal bleeding were divided into haematemesis vs non-haematemesis (73 vs 28). For patients with haematemesis, 37 received early endoscopy and 36 received delayed endoscopy, whereas for non-haematemesis, 12 received early endoscopy and 11 received delayed endoscopy | Cohort study | 6-week mortality | (In haematemesis group, early vs delayed) 27% vs 52.8%, P=0.031. Statistically significant (In non-haematemesis group, early vs delayed) 11.8% vs 9.1%, P=0.861. No statistical significance | Small sample size. |
6-week rebleeding | (In haematemesis group, early vs delayed) 18.9% vs 38.9%, P=0.028. Statistically significant (in non-haematemesis group, early vs delayed) 17.6% vs 18.2%, P=0.994. No statistical significance. No significant difference in haematemesis group who received early endoscopy and non-hametemsis who received either early or delayed endoscopy | ||||
Jairath V et al 2012 UK | 4478 patients admitted with acute NVUGIB. 834 received endoscopy in <12 hours, 1190 receive endoscopy between 12-24 hours and 2158 received endoscopy >24 hours | Prospective comparative study | Mortality | Adjusted for confounding factors (<24 hours) OR 0.99, 95% CI 0.97-1.02) (>24 hours) OR 0.98, 95% CI 0.88-1.09 P=0.7, not statistically significant | 296 patients with missing “time to endoscopy” which was imputed by sensitive analysis |
Re-bleeding | Adjusted for confounding factors (<24 hours) OR 0.99, 95% CI 0.96-1.01; (>24 hours) OR 0.95, 95% CI 0.87-1.04 P=0.27, not statistically significant | ||||
Need for surgical or radiological intervention | Adjusted for confounding factors (<24 hours) OR 0.99, 95% CI 0.94-1.03; (>24 hours) OR 0.95, 95% CI 0.80-1.11 P=0.5, not statistically significant | ||||
Red cell transfusion | Adjusted for confounding factors (<24 hours) OR 0.81, 95% CI 0.74-0.89; (>24 hours) OR 0.66, 95% CI 0.55-0.80 P<0.001, statistically significant | ||||
Length of hospital stay (difference in mean days) | Adjusted for confounding factors (<24 hours) OR 0.44, 95% CI 0.36-0.52; (>24 hours) OR 1.69, 95% CI 1.39-1.99 P<0.001, statistically significant | ||||
Liu et al 2012 China | 875 patients with peptic ulcer bleeding were analysed after randomization to receive either standard regime (n=456) or intensive regime (n=419) of PPI. They were further subdivided based on early (n=365) or late (n=510) endoscopy Standard, early vs late (182 vs 274) Intensive, early vs late (183 vs 236) | RCT | Re-bleeding | Early vs late, 7.1% vs 10.0%, P=0.14 Not statistically significant even when compared between subgroups receiving either standard or intensive PPI regime | PPI formulation used varied throughout duration of study Not all patients underwent H.pylori testing No standardization for methods of endoscopy haemostasis Only tested on a very specific group of patients as relatively high risk patients were excluded) |
No. of units of blood transfused | Early vs late, 0.90 ± 1.76 vs 2.26 ± 2.48, P<0.001 Statistically significant even when compared between subgroups receiving either standard or intensive PPI regime | ||||
Hospital stay (days) | Early vs late, 6.8 ± 4.6 vs 8.8 ± 5.8, P<0.001 Statistically significant even when compared between subgroups receiving either standard or intensive PPI regime | ||||
Sarin et al 2009 Canada | 502 patients with suspected UGIB receiving endoscopy within 6h, 6-24h and >24h. 375 patients identified as acute nonvariceal UGIB which was studied for primary outcome | Retrospective analysis | Mortality/ Need for surgery | 6h vs >24h (OR 3.6, 95% CI 1.4-9.4, P=0.008) 6-24 h vs >24h (OR 2.8, 95% CI 1.3-6.2, P=0.01) | Unclear management of patient prior to endoscopy i.e how haemodynamically unstable patients were managed as it may affect patient outcome. Outcome result from multivariate analysis only reported patients with acute nonvariceal bleed |
Need for transfusion | Time to endoscopy not significantly associated with need for transfusion | ||||
Cheung et al 2009 Canada | 210 patients with stable acute variceal bleed (AVB) | Retrospective analysis | Mortality | OR, 1.0; 95% CI, 0.92–1.08; P=0.91 No statistically significant difference across different time to endoscopy (<4h, <8h and <12h). | |
Haemostasis | <4h vs <8h vs <12 h (P=0.93 vs P=0.75 vs P=0.67) No statistically significant difference across different time | ||||
Blood transfusion (units) | <4h vs <8h vs <12 h (P=0.08 vs P=0.14 vs P=0.93) No statistically significant difference across different time | ||||
Rebleeding | <4h vs <8h vs <12 h (P=0.46 vs P=0.58 vs P=0.37) No statistically significant difference across different time | ||||
Day 3 creatinine | <4h vs <8h vs <12 h (P=0.69 vs P=0.22 vs P=0.12) No statistically significant difference across different time | ||||
Length of hospitalization (days) | <4h vs <8h vs <12 h (P=0.87 vs P=0.99 vs P=0.41) No statistically significant difference across different time | ||||
TIPS use | <4h vs <8h vs <12 h (P=0.27 vs P=0.11 vs P=0.86) No statistically significant difference across different time | ||||
Balloon tamponade use | <4h vs <8h vs <12 h (P=0.29 vs P=0.29 vs P=0.13) No statistically significant difference across different time |